Back to search

Article

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients

2019-11-11

Abstract excerpt

<h4>Background: </h4> Recent efforts have described an immunogenic component to the pathobiology of Alzheimer’s disease (AD) and Parkinson’s disease (PD). However, current methods of studying fluid autoantibodies, such as enzyme-linked immunosorbent assays and immunohistochemistry, are hypothesis-driven and not optimal for discovering new autoantibody biomarkers by proteome-wide screening. Recently, we developed a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c5b2c1a-23fb-57ff-87c8-832322061ba9
DOI
10.12688/f1000research.21140.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patientsDOI 10.12688/f1000research.21140.1
Identification of novel candidate autoantibodies in Alzheimer’s diseaseSemantic proximity
Alzheimer Disease Pathogenesis: The Role of AutoimmunitySemantic proximity
Artificial intelligence and omics-based autoantibody profiling highlights autoimmunity targeting ligand-receptor interaction in dementiaSemantic proximity
Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human SeraSemantic proximity
A combination of multiple autoantibodies is associated with the risk of Alzheimer’s disease and cognitive impairmentSemantic proximity
Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s diseaseSemantic proximity
The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity
Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the FutureSemantic proximity
Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.Semantic proximity
Novel exosome biomarker candidates for Alzheimer´s disease unraveled through Mass Spectrometry analysisSemantic proximity
Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseasesSemantic proximity
Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.Semantic proximity
Select a neighboring publication to make it the new centre.